Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" google.com

Clinical Trial: Clinical Trail to Evaluate the Effect of Long-term Treatment With Gecacitinib on ...

google.com·17w

Nutritional Status Shown to Strongly Predict Survival in Patients With MF

google.com·18w

Platelet recovery delay and survival in patients with myelofibrosis undergoing ...

google.com·18w

Australian researchers develop targeted therapy for rare blood cancer

google.com·18w

GSK 'Omjjara' expecting to get reimbursement greenlight

google.com·18w

Pacritinib Therapy Shows Improved Symptom Reduction and Spleen Response for Patients ...

google.com·18w

Ropeginterferon Alfa-2b Under Review for Essential Thrombocythemia

google.com·18w

Myelofibrosis Market in the 7MM is projected to grow at a CAGR of 9%

google.com·18w

Myelofibrosis Market in the 7MM is projected to grow at a CAGR of 9% by 2034, estimates ...

google.com·18w

Disc Medicine prepares for potential 2026 bitopertin FDA decision

google.com·18w

What Blood Cancer Does Anna Have On GH? Her Polycythemia Vera Explained

google.com·18w

PharmaEssentia's sBLA in essential thrombocythemia accepted by FDA

google.com·18w

Agios Pharma Sets 2026 Strategic Priorities After AQVESME Approval

google.com·18w

FDA Accepts sBLA for Ropeginterferon-Alfa-2b for Essential Thrombocythemia

google.com·18w

FDA Accepts Besremi Application for Essential Thrombocythemia

google.com·18w

FDA Confirms a PDUFA Goal Date of August 30, 2026 for the sBLA Submission of ...

google.com·18w

US FDA OKs PharmaEssentia's License for Essential Thrombocythemia Drug

google.com·18w

FDA Confirms a PDUFA Goal Date of August 30, 2026 for the sBLA Submission of ...

google.com·18w

Targeted 'therapy' offers hope for rare blood cancer

google.com·18w

Australian Researchers Develop Targeted Therapy Approach for Rare Blood Cancer

google.com·18w

Log in to enable infinite scrolling